WHO ICTRP trial

A clinical study to assess the effectiveness and safety of bovine bone collagen…

CTRI/2009/091/000992 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2009/091/000992
Public title A clinical study to assess the effectiveness and safety of bovine bone collagen peptide in patients with knee joint osteoarthritis
Scientific title A double blind, placebo controlled, randomized trial to determine the effectiveness and safety of bovine bone collagen peptide as add-on nutritional supplement in management of subjects with knee joint osteoarthritis
Primary sponsor MS Nitta Gelatin India Limited Cochin INDIA
Secondary sponsors Aurous HealthCare Research and Development India Private Limited
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Phase Phase 3
Countries India
Conditions Health Condition 1: M179- Osteoarthritis of knee, unspecified
Interventions Intervention1: collagen peptite of bovine bone origin: oral powder,10 gm/day, 13 weeks Control Intervention1: placebo: oral powder,10 gm/day, 13 weeks
Registration date Jan 15, 2010
Target size 30
Secondary IDs AHC/ORT/002/09 VersionNo.03;U1111-1112-6561
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations